BAYER AG-REG (BAYN.DE) Stock Fundamental Analysis
Europe - Frankfurt Stock Exchange - FRA:BAYN - DE000BAY0017 - Common Stock
35.94 EUR
+0.48 (+1.37%)
BAYN gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 54 industry peers in the Pharmaceuticals industry. BAYN may be in some trouble as it scores bad on both profitability and health. BAYN is cheap, but on the other hand it scores bad on growth.
1. Profitability
1.1 Basic Checks
In the past year BAYN was profitable.
BAYN had a positive operating cash flow in the past year.
In multiple years BAYN reported negative net income over the last 5 years.
Each year in the past 5 years BAYN had a positive operating cash flow.
1.2 Ratios
The Return On Assets of BAYN (-0.19%) is worse than 64.81% of its industry peers.
The Return On Equity of BAYN (-0.67%) is worse than 64.81% of its industry peers.
BAYN has a Return On Invested Capital of 1.80%. This is in the lower half of the industry: BAYN underperforms 64.81% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for BAYN is significantly below the industry average of 13.79%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.19% | ||
| ROE | -0.67% | ||
| ROIC | 1.8% |
ROA(3y)-0.5%
ROA(5y)-1.93%
ROE(3y)-2.08%
ROE(5y)-7.52%
ROIC(3y)5.51%
ROIC(5y)N/A
1.3 Margins
Looking at the Operating Margin, with a value of 4.20%, BAYN is doing worse than 64.81% of the companies in the same industry.
BAYN's Operating Margin has declined in the last couple of years.
With a Gross Margin value of 56.35%, BAYN is not doing good in the industry: 68.52% of the companies in the same industry are doing better.
BAYN's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 4.2% | ||
| PM (TTM) | N/A | ||
| GM | 56.35% |
OM growth 3Y-18.1%
OM growth 5Y-4.34%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.21%
GM growth 5Y-1.81%
2. Health
2.1 Basic Checks
BAYN has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for BAYN remains at a similar level compared to 1 year ago.
Compared to 5 years ago, BAYN has about the same amount of shares outstanding.
BAYN has a better debt/assets ratio than last year.
2.2 Solvency
Based on the Altman-Z score of 0.95, we must say that BAYN is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of 0.95, BAYN is not doing good in the industry: 70.37% of the companies in the same industry are doing better.
BAYN has a debt to FCF ratio of 10.07. This is a negative value and a sign of low solvency as BAYN would need 10.07 years to pay back of all of its debts.
BAYN has a Debt to FCF ratio of 10.07. This is in the lower half of the industry: BAYN underperforms 66.67% of its industry peers.
A Debt/Equity ratio of 1.11 is on the high side and indicates that BAYN has dependencies on debt financing.
BAYN's Debt to Equity ratio of 1.11 is on the low side compared to the rest of the industry. BAYN is outperformed by 70.37% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.11 | ||
| Debt/FCF | 10.07 | ||
| Altman-Z | 0.95 |
ROIC/WACC0.26
WACC6.82%
2.3 Liquidity
A Current Ratio of 1.14 indicates that BAYN should not have too much problems paying its short term obligations.
BAYN has a worse Current ratio (1.14) than 68.52% of its industry peers.
BAYN has a Quick Ratio of 1.14. This is a bad value and indicates that BAYN is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.71, BAYN is doing worse than 75.93% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.14 | ||
| Quick Ratio | 0.71 |
3. Growth
3.1 Past
BAYN shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -8.72%.
Measured over the past years, BAYN shows a decrease in Earnings Per Share. The EPS has been decreasing by -5.27% on average per year.
The Revenue has decreased by -1.87% in the past year.
BAYN shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 1.37% yearly.
EPS 1Y (TTM)-8.72%
EPS 3Y-8.12%
EPS 5Y-5.27%
EPS Q2Q%137.5%
Revenue 1Y (TTM)-1.87%
Revenue growth 3Y1.87%
Revenue growth 5Y1.37%
Sales Q2Q%-3.09%
3.2 Future
BAYN is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 3.48% yearly.
The Revenue is expected to grow by 1.44% on average over the next years.
EPS Next Y-5.62%
EPS Next 2Y-1.83%
EPS Next 3Y1.53%
EPS Next 5Y3.48%
Revenue Next Year-1.51%
Revenue Next 2Y-0.28%
Revenue Next 3Y0.53%
Revenue Next 5Y1.44%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 6.73, the valuation of BAYN can be described as very cheap.
BAYN's Price/Earnings ratio is rather cheap when compared to the industry. BAYN is cheaper than 96.30% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 26.50. BAYN is valued rather cheaply when compared to this.
BAYN is valuated cheaply with a Price/Forward Earnings ratio of 7.38.
94.44% of the companies in the same industry are more expensive than BAYN, based on the Price/Forward Earnings ratio.
The average S&P500 Price/Forward Earnings ratio is at 23.93. BAYN is valued rather cheaply when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 6.73 | ||
| Fwd PE | 7.38 |
4.2 Price Multiples
BAYN's Enterprise Value to EBITDA is on the same level as the industry average.
Based on the Price/Free Cash Flow ratio, BAYN is valued cheaper than 88.89% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 8.97 | ||
| EV/EBITDA | 10.8 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-1.83%
EPS Next 3Y1.53%
5. Dividend
5.1 Amount
With a yearly dividend of 0.31%, BAYN is not a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 1.85, BAYN is paying slightly less dividend.
Compared to an average S&P500 Dividend Yield of 1.87, BAYN's dividend is way lower than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.31% |
5.2 History
The dividend of BAYN decreases each year by -45.34%.
Dividend Growth(5Y)-45.34%
Div Incr Years0
Div Non Decr Years3
5.3 Sustainability
BAYN has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-65.15%
EPS Next 2Y-1.83%
EPS Next 3Y1.53%
FRA:BAYN (12/23/2025, 7:00:00 PM)
35.94
+0.48 (+1.37%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)
Earnings (Next)
Inst Owners48.44%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap35.31B
Revenue(TTM)45.87B
Net Income(TTM)-198.00M
Analysts71.43
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.31% |
Yearly Dividend0.13
Dividend Growth(5Y)-45.34%
DP-65.15%
Div Incr Years0
Div Non Decr Years3
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)58.52%
Min EPS beat(2)45.89%
Max EPS beat(2)71.16%
EPS beat(4)4
Avg EPS beat(4)30.58%
Min EPS beat(4)1.86%
Max EPS beat(4)71.16%
EPS beat(8)7
Avg EPS beat(8)18.15%
EPS beat(12)9
Avg EPS beat(12)7.9%
EPS beat(16)12
Avg EPS beat(16)7.93%
Revenue beat(2)0
Avg Revenue beat(2)-2.53%
Min Revenue beat(2)-2.63%
Max Revenue beat(2)-2.42%
Revenue beat(4)1
Avg Revenue beat(4)-1.06%
Min Revenue beat(4)-2.63%
Max Revenue beat(4)1.79%
Revenue beat(8)2
Avg Revenue beat(8)-1.69%
Revenue beat(12)2
Avg Revenue beat(12)-2.67%
Revenue beat(16)6
Avg Revenue beat(16)-1.42%
PT rev (1m)12.1%
PT rev (3m)12%
EPS NQ rev (1m)-25.09%
EPS NQ rev (3m)-37.41%
EPS NY rev (1m)0.93%
EPS NY rev (3m)0.91%
Revenue NQ rev (1m)0.07%
Revenue NQ rev (3m)-2.4%
Revenue NY rev (1m)-0.14%
Revenue NY rev (3m)-0.34%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 6.73 | ||
| Fwd PE | 7.38 | ||
| P/S | 0.77 | ||
| P/FCF | 8.97 | ||
| P/OCF | 5.25 | ||
| P/B | 1.19 | ||
| P/tB | N/A | ||
| EV/EBITDA | 10.8 |
EPS(TTM)5.34
EY14.86%
EPS(NY)4.87
Fwd EY13.54%
FCF(TTM)4.01
FCFY11.14%
OCF(TTM)6.84
OCFY19.04%
SpS46.69
BVpS30.11
TBVpS-18.8
PEG (NY)N/A
PEG (5Y)N/A
Graham Number60.14
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.19% | ||
| ROE | -0.67% | ||
| ROCE | 2.56% | ||
| ROIC | 1.8% | ||
| ROICexc | 2% | ||
| ROICexgc | 6.8% | ||
| OM | 4.2% | ||
| PM (TTM) | N/A | ||
| GM | 56.35% | ||
| FCFM | 8.58% |
ROA(3y)-0.5%
ROA(5y)-1.93%
ROE(3y)-2.08%
ROE(5y)-7.52%
ROIC(3y)5.51%
ROIC(5y)N/A
ROICexc(3y)6.21%
ROICexc(5y)N/A
ROICexgc(3y)25.79%
ROICexgc(5y)N/A
ROCE(3y)7.82%
ROCE(5y)N/A
ROICexgc growth 3Y-23.46%
ROICexgc growth 5Y-1.27%
ROICexc growth 3Y-13.2%
ROICexc growth 5Y2.54%
OM growth 3Y-18.1%
OM growth 5Y-4.34%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.21%
GM growth 5Y-1.81%
F-Score5
Asset Turnover0.44
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.11 | ||
| Debt/FCF | 10.07 | ||
| Debt/EBITDA | 5.32 | ||
| Cap/Depr | 66.1% | ||
| Cap/Sales | 6.08% | ||
| Interest Coverage | 1.09 | ||
| Cash Conversion | 109.39% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.14 | ||
| Quick Ratio | 0.71 | ||
| Altman-Z | 0.95 |
F-Score5
WACC6.82%
ROIC/WACC0.26
Cap/Depr(3y)34.81%
Cap/Depr(5y)41.62%
Cap/Sales(3y)5.85%
Cap/Sales(5y)5.86%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-8.72%
EPS 3Y-8.12%
EPS 5Y-5.27%
EPS Q2Q%137.5%
EPS Next Y-5.62%
EPS Next 2Y-1.83%
EPS Next 3Y1.53%
EPS Next 5Y3.48%
Revenue 1Y (TTM)-1.87%
Revenue growth 3Y1.87%
Revenue growth 5Y1.37%
Sales Q2Q%-3.09%
Revenue Next Year-1.51%
Revenue Next 2Y-0.28%
Revenue Next 3Y0.53%
Revenue Next 5Y1.44%
EBIT growth 1Y-2.82%
EBIT growth 3Y-16.56%
EBIT growth 5Y-3.03%
EBIT Next Year65.17%
EBIT Next 3Y21.41%
EBIT Next 5Y11.27%
FCF growth 1Y873.08%
FCF growth 3Y22.16%
FCF growth 5Y-3.69%
OCF growth 1Y161.6%
OCF growth 3Y12.83%
OCF growth 5Y-2.09%
BAYER AG-REG / BAYN.DE FAQ
What is the fundamental rating for BAYN stock?
ChartMill assigns a fundamental rating of 3 / 10 to BAYN.DE.
What is the valuation status for BAYN stock?
ChartMill assigns a valuation rating of 7 / 10 to BAYER AG-REG (BAYN.DE). This can be considered as Undervalued.
How profitable is BAYER AG-REG (BAYN.DE) stock?
BAYER AG-REG (BAYN.DE) has a profitability rating of 2 / 10.
Can you provide the expected EPS growth for BAYN stock?
The Earnings per Share (EPS) of BAYER AG-REG (BAYN.DE) is expected to decline by -5.62% in the next year.
Is the dividend of BAYER AG-REG sustainable?
The dividend rating of BAYER AG-REG (BAYN.DE) is 0 / 10 and the dividend payout ratio is -65.15%.